Diabetes Research and Clinical Practice
Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity
Cohort study of 335,605 peoplePopulations
Declared ties to: Syneos Health, American Diabetes Association, National Institute of Diabetes and 5 more
- Sodium-glucose cotransporter 2 inhibitors
- Bariatric surgery
- GLP-1 and incretin signalling
- Obesity
- Type 2 diabetes
- Humans
The paper
Kaiser Permanente Washington Health Research Institute; University of Maryland, Baltimore
Diabetes Research and Clinical Practice, 20 Aug 2026
